BENZODIAZEPINE USE IN GENERAL POPULATION, THE MUNICIPALITY OF BERANE, MONTENEGRO
Abstract
Background: Benzodiazepines can be classified as one of the most frequently prescribed categories of medication. This medication category is distinguished by a high risk of tolerance and dependence, in the case of long-term, excessive use.
Aim: The aim of our study was to analyse the use of benzodiazepines in the general population, municipality of Berane, Montenegro, during the previous year.
Methods: Research was based on the analysis of 1000 prescriptions of benzodiazepines, issued by physicians in Primary Health Care. The diagnostic manual utilised for the purpose of this research was International Classification of Diseases (ICD-10). The survey was conducted for a period of 40 days during January and February 2015.
Results: The study was performed in the general population, age from 18 to 98 years (621 females and 379 males). The average age of all participants in the study was 64.1± 13.1 years. Analysis of data confirmed that the most frequently prescribed from the group of benzodiazepines were: diazepam (42.2%), bromazepam (30.3%), lorazepam (16.4%), alprazolam (6.4%), nitrazepam (2.6%) and clonazepam (2.1%). The significant statistical difference (χ²=58.664; p<0.001) was found between female patients who used benzodiazepines in 62.1% of cases, compared to male patients who used benzodiazepines in 37.9% of cases. It was confirmed that benzodiazepines were usually prescribed for 17 different diagnoses, mostly for diagnoses from the group I, viz. cluster-diseases of the circulatory system (39.7%), group F-mental and behavioural disorders (31.1%) and group E-endocrine, nutritional and metabolic diseases (7.7%).
Conclusion: Studies about drug utilisation provide plenty of useful information which can be further used with the aim of achieving more rational prescribing and more effective patient treating.
References
World Health Organization. Rational use of benzodiazepines. Document WHO/PSA/96.11, Geneva, 1996.
Францетић И. Фармакотерапијски приручник. 6 Изд. Загреб: Медицинска наклада, 2010.
Rang H.P, Dale M.M, Ritter J.M, Moore P.K. Фармакологија. 5 Изд. Београд: Data Status, 2005.
Богословић М, Потић М, Митровић Д. Употреба бензодиазепина код пацијената у ординацији изабраног лекара у Дому здравља Дољевац. Тимочки медицински гласник 2012; 37(3): 150-3.
Кажић Т. Готови љекови: приручник за фармакотерапију. 11 Изд. Београд: Integra, 2013.
Вујић З, Васиљевић Д. Структурне карактеристике антидепресива и анксиолитика. 11. Симпозијум магистара фармације и медицинске биохемије Републике Српске 2014; 16-25.
Мимица Н, Фолнеговић-Шмалц В, Узун С, Рушиновић М. Бензодиазепини: за и против. Medicus 2002; 11(2): 183-8.
Угрешић Н. Фармакологија анксиолитика. Архив за фармацију 2007; 57: 106-17.
Аshton H. The diagnosis and management of benzodiazepine dependence. Current Opinion in Psychiatry 2005; 18: 249–55.
Станетић К, Савић С. Употреба бензодиазепина код пацијената лијечених у Дому здравља Бања Лука. Општа медицина 2010; 16(1-2): 50-5.
Kafeel H, Rukh R, Iqbal J, Naveed S. Irrational dispensing and self medication of benzodiazepines by general population of a big city. Journal of Pharmaceutical and Scientific Innovation 2014; 3(2): 178-81.
Donato F, Samani F, Marini M et al. Across-sectional survey on benzodiazepine use among older people in an Italian region. Italian Journal of Public Health 2005; 2(2): 42-8.
Lagnaoui R, Depont F, Fourrier A et al. Patterns and correlates of benzodiazepine use in the French general population. European Journal of Clinical Pharmacology 2004; 60(7): 523-9.
Gleason PP, Schulz R, Smith NL et al. Correlates and Prevalence of Benzodiazepine Use in Community - Dwelling Elderly. Journal of General Internal Medicine 1998; 13(4): 243-50.
Nordon DG, Akamine K, Novo NF, Hübner CK. Characteristics of the use of benzodiazepines by women seeking treatment in primary care. Revista de Psiquiatria do Rio Grande do Sul 2009; 31(3): 152-8.